Medical
The Medical Clinical Trials Team conducts clinical trials of new drugs in blood cancers and disorders (Haematology), liver disorders (Hepatology), diabetes and metabolic disorders (Endocrinology).
BGB-16673 - BTK-Degrader in combination for Relapsed or Refractory B-Cell Malignancies
FAME 1 Eye research study - A new treatment for retinopathy in type 1 diabetes
Testing the safety and effectiveness of Fenofibrate in reducing diabetic retinopathy in adults with Type 1 diabetes
frontMIND - A new treatment for newly diagnosed lymphoma
A clinical trial of investigational drug tafasitamab plus lenalidomide in addition to standard therapy for treatment of newly diagnosed high and intermediate risk diffuse large B-cell lymphoma (DLBCL)
GOLSEEK-2 - Golcadomide plus Rituximab for Follicular Lymphoma
A Study to Assess the Efficacy and Safety of Golcadomide and Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lymphoma
Phenylketonuria (PKU): An early phase trial of a new treatment for PKU
This study is trialing a novel drug, called JNT-517, which works by increasing excretion of phenylalanine in the urine to reduce circulating levels in the blood.
RAISE A clinical trial of a ganaxalone in status epilepticus
ZOvCa - A phase 1 PET-CT study of 89Zr-hu/mo-10D7 in patients with advanced epithelial Ovarian Cancer
The primary aim of this clinical trial is to test the safety of a new imaging agent in patients with epithelial ovarian cancer.